-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

ASH Poster Walk on the Spectrum of Hemostasis and Thrombosis Research

Program: ASH Poster Walks
Hematology Disease Topics & Pathways:
Research, Clinical Trials, Bleeding and Clotting, bleeding disorders, Clinical Practice (Health Services and Quality), Epidemiology, hemophilia, Workforce, Health Outcomes Research, platelet disorders, Diversity, Equity, Inclusion, and Accessibility (DEI/DEIA) , thromboembolism, Patient-Reported Outcomes, Diseases, thrombocytopenias, Real World Evidence, thrombotic disorders, Registries, VWD
Thursday, December 16, 2021: 5:00 PM-6:00 PM
Please view the recorded poster presentations prior to attending this virtual session:

Non-malignant hematology covers a broad range of topics. The purpose of the ASH Poster Walk on the Spectrum of Hemostasis and Thrombosis Research is to highlight a clinical and a translational/basic science abstract in hemostasis, thrombosis, and platelet disorders to foster discussion across disciplines and to encourage young investigators to pursue this career path. Trainees/junior faculty will have a unique opportunity to meet with leaders in the field of hemostasis and thrombosis, get exposure to various topics within non-malignant hematology, and to learn how to interpret the data presented in a poster.

The following abstracts will be featured in this session:

Predicting Chronic Immune Thrombocytopenia in Pediatric Patients at Disease Presentation: Leveraging Clinical and Laboratory Characteristics Via Machine Learning Models, Derek MacMath

Prevention of Fetal/Neonatal Alloimmune Thrombocytopenia in a Preclinical Model By Monoclonal Anti-HPA-1a Antibody Prophylaxis: Structural and Functional Properties of Antibody Variant Isoforms, Trude Mortberg

The Anticoagulant Properties of Protamine: New Mechanistic Insights into Its Interaction with Factor V, Teodolinda Petrillo

Bleeding in Patients with Clinically Severe Von Willebrand Disease: Interim Analysis of Athn 9: A Natural History Study for People with Severe Von Willebrand Disease (VWD), Robert Sidonio

Extra-Splenic Role of B Cell Activating Factor Blockade in Prevention of Factor VIII Inhibitors, Bhavya Doshi

See more of: ASH Poster Walks
<< Previous Poster Walk Application | Next Poster Walk Application >>